{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics","slug":"episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics","published_at":"2025-05-28T09:13:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2051355/c1e-d515ntmkjjvu0ogqx-kp4qxj82bw06-qdksuh.mp3","summary":"The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Michael Tolentino, MD, Co-Founder and Head Scientific Consultant at Aviceda Therapeutics, to the podcast. Tune in to part one of this special two-part episode as we explore Michael's start in ophthalmology, groundbreaking treatments in intra-retinal therapy, and the importance of being a great communicator. Okay, let's start the podcast!","meta_description":"The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between podcast. Host Ch…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2711,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}